{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-020227","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2023-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.479653+00:00","generated_at":"2026-06-13T06:23:01.741967+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Genprex raises $7.5M gross in registered direct offering of stock and warrants","bullets":["Offering of 7,425,744 shares plus warrants for same number at $1.01 per unit.","Warrants exercisable at $0.885 per share, 5-year term, immediate exercisability.","Gross proceeds expected ~$7.5M; net proceeds ~$6.7M after fees and expenses.","Proceeds to be used for working capital and general corporate purposes.","H.C. Wainwright acts as exclusive placement agent; offering closes July 21, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-020227","json":"https://secwatch.observer/filing/0001437749-23-020227.json","markdown":"https://secwatch.observer/filing/0001437749-23-020227.md","text":"https://secwatch.observer/filing/0001437749-23-020227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923020227/0001437749-23-020227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923020227/gnpx20230717_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T06:23:01.741967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"527e686c0eeb0b2417bfd0616946a0d5d4965f72","claim":"Genprex, Inc. entered into Purchase Agreement with accredited healthcare-focused institutional investors valued at approximately $6.7 million (effective 2023-07-18).","evidence_excerpt":"On July 18, 2023, Genprex, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with accredited healthcare-focused institutional investors (the “Purchasers”) pursuant to which the Company agreed to issue and sell to the Purchasers, in a registered direct offering (the “Offering”) priced at the market under Nasdaq rules, an aggregate of (i) 7,425,744 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) warrants (the “Warrants”) exercisable for up to an aggregate of 7,425,744 shares of Common Stock.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923020227/0001437749-23-020227-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited healthcare-focused institutional investors"},{"label":"Value","value":"approximately $6.7 million"},{"label":"Effective","value":"2023-07-18"}],"fact_type":"material_agreement"},{"claim_id":"f7c732dd3ecc47fd71b31bea0f2a60b2b8f6c7cc","claim":"Genprex, Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC.","evidence_excerpt":"Pursuant to an Engagement Letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (the “Placement Agent”), the Company agreed to pay the Placement Agent in connection with the Offering (i) a cash fee equal to 7.0% of the aggregate gross proceeds received in the Offering, (ii) a management fee equal to 1.0% of the aggregate gross proceeds of the Offering, (iii) $50,000 for fees and expenses of the Placement Agent’s counsel and other out of pocket expenses, (iv) a non-accountable expense allowance of $25,000 and (v) $15,950 for the clearing expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923020227/0001437749-23-020227-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}